The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Cardiff Oncology Inc’s stock clocked out at $2.53, up 2.85% from its previous closing price of $2.46. In other words, the price has increased by $2.85 from its previous closing price. On the day, 0.61 million shares were traded. CRDF stock price reached its highest trading level at $2.705 during the session, while it also had its lowest trading level at $2.47.
Ratios:
To gain a deeper understanding of CRDF’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.97 and its Current Ratio is at 4.97. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on September 06, 2024, initiated with a Buy rating and assigned the stock a target price of $8.
On December 08, 2021, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $19.Robert W. Baird initiated its Outperform rating on December 08, 2021, with a $19 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 19 ’23 when PACE GARY W bought 30,000 shares for $1.37 per share. The transaction valued at 41,100 led to the insider holds 697,761 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRDF now has a Market Capitalization of 117770488 and an Enterprise Value of 59294576. For the stock, the TTM Price-to-Sale (P/S) ratio is 175.78 while its Price-to-Book (P/B) ratio in mrq is 2.20. Its current Enterprise Value per Revenue stands at 89.165 whereas that against EBITDA is -1.341.
Stock Price History:
Over the past 52 weeks, CRDF has reached a high of $6.42, while it has fallen to a 52-week low of $0.94. The 50-Day Moving Average of the stock is 8.21%, while the 200-Day Moving Average is calculated to be -9.15%.
Shares Statistics:
It appears that CRDF traded 549.77K shares on average per day over the past three months and 475240 shares per day over the past ten days. A total of 44.68M shares are outstanding, with a floating share count of 42.93M. Insiders hold about 7.77% of the company’s shares, while institutions hold 27.92% stake in the company. Shares short for CRDF as of 1724976000 were 6902749 with a Short Ratio of 12.56, compared to 1722384000 on 5783089. Therefore, it implies a Short% of Shares Outstanding of 6902749 and a Short% of Float of 15.25.
